Mepron (antipneumocystic) | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Mepron (antipneumocystic)
Health Canada Patents

PharmaCompass Sponsored Ads

Contact Supplier

Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

Contact Supplier

Bhavna Laboratories is an API & Intermediate manufacturer focusing on the muscle relaxant & ophthalmic segments.

Contact Supplier

Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

Contact Supplier

Quotient Sciences- Molecule to Cure. Fast.

Contact Supplier

pharmacompass-2-m-2025-08-25

Mepron (antipneumocystic)

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

25 API Suppliers, 13 USDMF, 6 CEP/COS, 4 EU WC, 11 NDC API, 12 Listed Suppliers, $ API Reference Price

25 API Suppliers
13 USDMF
6 CEP/COS
4 EU WC
11 NDC API
12 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

9 Drugs in Development

9 Drugs in Development

INTERMEDIATES

4 Intermediate Suppliers

4 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

51 FDF Dossiers, 17 FDA Orange Book, 14 Europe, 8 Canada, 2 Australia, 9 South Africa, 1 Listed Dossiers

51 FDF Dossiers
17 FDA Orange Book
14 Europe
8 Canada
2 Australia
9 South Africa
1 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SUSPENSION;ORAL - 750MG/5ML, TABLET;ORAL - 250MG;100MG, TABLET;ORAL - 62.5MG;25MG

SUSPENSION;ORAL - 750MG/5ML
TABLET;ORAL - 250MG;100MG
TABLET;ORAL - 62.5MG;25MG

RELATED EXCIPIENT COMPANIES

2 Rochem International Inc, 1 SPI Pharma, 9 DKSH, 1 Pharm-RX Chemical, 8 Boai NKY Pharmaceuticals Ltd, 4 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 1 Kirsch Pharma, 1 ACG Worldwide, 5 Actylis, 1 Alcedo Pharmachem, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 23 BASF, 1 CD Formulation, 1 Clariant, 10 Corel Pharma Chem, 5 DFE Pharma, 1 Esteem Industries, 2 Finar, 8 Gangwal Chemicals, 4 Ideal Cures, 1 Ingredion Pharma Solutions, 20 Kerry, 2 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 12 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 3 Novo Excipients, 4 Pharmatrans-Sanaq, 3 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 11 Roquette, 6 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 9 Sigachi Industries, 3 Silverline Chemicals, 2 The Dow Chemical Company, 2 Ulanqab Kema New Material, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

44 Fillers, Diluents & Binders, 41 Coating Systems & Additives, 28 Disintegrants & Superdisintegrants, 25 Granulation, 25 Thickeners and Stabilizers, 23 Direct Compression, 22 Controlled & Modified Release, 16 Solubilizers, 14 Topical, 12 Lubricants & Glidants, 10 Co-Processed Excipients, 9 Film Formers & Plasticizers, 8 Rheology Modifiers, 8 Chewable & Orodispersible Aids, 6 Parenteral, 6 API Stability Enhancers, 6 Taste Masking, 5 Empty Capsules, 5 Coloring Agents, 5 Emulsifying Agents, 4 Vegetarian Capsules, 2 Surfactant & Foaming Agents

44 Fillers, Diluents & Binders
41 Coating Systems & Additives
28 Disintegrants & Superdisintegrants
25 Granulation
25 Thickeners and Stabilizers
23 Direct Compression
22 Controlled & Modified Release
16 Solubilizers
14 Topical
12 Lubricants & Glidants
10 Co-Processed Excipients
9 Film Formers & Plasticizers
8 Rheology Modifiers
8 Chewable & Orodispersible Aids
6 Parenteral
6 API Stability Enhancers
6 Taste Masking
5 Empty Capsules
5 Coloring Agents
5 Emulsifying Agents
4 Vegetarian Capsules
2 Surfactant & Foaming Agents

DIGITAL CONTENT

22 News #PharmaBuzz

22 News #PharmaBuzz

GLOBAL SALES INFORMATION

16 US Medicaid Prescriptions, 12 Regulatory FDF Prices

16 US Medicaid Prescriptions
12 Regulatory FDF Prices

MARKET PLACE

2 APIs, 1 FDF Dossiers

2 APIs
1 FDF Dossiers

PATENTS & EXCLUSIVITIES

6 Health Canada Patents

6 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 2 Others

2 EDQM
2 Others

$ API Ref.Price (USD/KG) : 1,194 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

6 All

01 6GlaxoSmithKline Inc.

filter Patent Reset all filters

6 All

01 11336266

02 22150234

03 32152615

filter Product Reset all filters

6 All

01 2Atovaquone

02 4Atovaquone | Proguanil Hydrochloride

filter Dosage Reset all filters

6 All

01 1Suspension

02 5Tablet

filter Exp Date Reset all filters

6 All

01 12012-07-11

02 22013-11-25

03 32013-12-23

Nuray Atovaquone

Product Main Page

01

GlaxoSmithKline Inc.

Atovaquone

Coatings Trends

Not Confirmed

GlaxoSmithKline Inc.

Coatings Trends

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2013-12-23

Date Granted : 2001-10-16

Brand Name : MEPRON

Patent Number : 2152615

Filing Date : 1993-12-23

Strength per Unit : 750 mg / 5ml

Dosage Form : Suspension

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2013-12-23

Date Granted : 2001-10-16

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

GlaxoSmithKline Inc.

Atovaquone, Proguanil Hydrochloride

Coatings Trends

Not Confirmed

GlaxoSmithKline Inc.

Coatings Trends

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2013-12-23

Date Granted : 2001-10-16

Atovaquone, Proguanil Hydrochloride

Brand Name : MALARONE

Patent Number : 2152615

Filing Date : 1993-12-23

Strength per Unit : 250mg Atovaquone / 100mg Proguanil Hydrochloride

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2013-12-23

Date Granted : 2001-10-16

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

GlaxoSmithKline Inc.

Atovaquone, Proguanil Hydrochloride

Coatings Trends

Not Confirmed

GlaxoSmithKline Inc.

Coatings Trends

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2013-11-25

Date Granted : 2005-03-22

Atovaquone, Proguanil Hydrochloride

Brand Name : MALARONE PEDIATRIC

Patent Number : 2150234

Filing Date : 1993-11-25

Strength per Unit : 62.5mg / 25mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2013-11-25

Date Granted : 2005-03-22

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

GlaxoSmithKline Inc.

Atovaquone, Proguanil Hydrochloride

Coatings Trends

Not Confirmed

GlaxoSmithKline Inc.

Coatings Trends

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2013-12-23

Date Granted : 2001-10-16

Atovaquone, Proguanil Hydrochloride

Brand Name : MALARONE PEDIATRIC

Patent Number : 2152615

Filing Date : 1993-12-23

Strength per Unit : 62.5mg / 25mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2013-12-23

Date Granted : 2001-10-16

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

GlaxoSmithKline Inc.

Atovaquone

Coatings Trends

Not Confirmed

GlaxoSmithKline Inc.

Coatings Trends

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2012-07-11

Date Granted : 1995-07-11

Brand Name : MEPRON

Patent Number : 1336266

Filing Date :

Strength per Unit : 250 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2012-07-11

Date Granted : 1995-07-11

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

GlaxoSmithKline Inc.

Atovaquone, Proguanil Hydrochloride

Coatings Trends

Not Confirmed

GlaxoSmithKline Inc.

Coatings Trends

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2013-11-25

Date Granted : 2005-03-22

Atovaquone, Proguanil Hydrochloride

Brand Name : MALARONE

Patent Number : 2150234

Filing Date : 1993-11-25

Strength per Unit : 250mg Atovaquone / 100mg Proguanil Hydrochloride

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2013-11-25

Date Granted : 2005-03-22

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!